Monogram Technologies Inc (MGRM)
2.06
-0.02
(-0.96%)
USD |
NASDAQ |
Jun 14, 16:00
2.01
-0.05
(-2.43%)
Pre-Market: 20:00
Monogram Technologies Research and Development Expense (Quarterly): 2.407M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.407M |
| December 31, 2023 | 3.636M |
| September 30, 2023 | 2.446M |
| June 30, 2023 | 2.738M |
| March 31, 2023 | 1.940M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.069M |
| September 30, 2022 | 1.169M |
| June 30, 2022 | 1.181M |
| March 31, 2022 | 0.9653M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.9653M
Minimum
Mar 2022
3.636M
Maximum
Dec 2023
2.061M
Average
2.069M
Median
Dec 2022
Research and Development Expense (Quarterly) Benchmarks
| Apyx Medical Corp | 1.397M |
| Nortech Systems Inc | 0.318M |
| Perspective Therapeutics Inc | 7.452M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |